Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 162

1.

Progesterone receptor-B regulation of insulin-like growth factor-stimulated cell migration in breast cancer cells via insulin receptor substrate-2.

Ibrahim YH, Byron SA, Cui X, Lee AV, Yee D.

Mol Cancer Res. 2008 Sep;6(9):1491-8. doi: 10.1158/1541-7786.MCR-07-2173.

PMID:
18819936
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Progesterone crosstalks with insulin-like growth factor signaling in breast cancer cells via induction of insulin receptor substrate-2.

Cui X, Lazard Z, Zhang P, Hopp TA, Lee AV.

Oncogene. 2003 Oct 9;22(44):6937-41.

PMID:
14534541
[PubMed - indexed for MEDLINE]
4.
6.

Differential insulin-like growth factor I receptor signaling and function in estrogen receptor (ER)-positive MCF-7 and ER-negative MDA-MB-231 breast cancer cells.

Bartucci M, Morelli C, Mauro L, Andò S, Surmacz E.

Cancer Res. 2001 Sep 15;61(18):6747-54.

PMID:
11559546
[PubMed - indexed for MEDLINE]
Free Article
7.

Tamoxifen interferes with the insulin-like growth factor I receptor (IGF-IR) signaling pathway in breast cancer cells.

Guvakova MA, Surmacz E.

Cancer Res. 1997 Jul 1;57(13):2606-10.

PMID:
9205064
[PubMed - indexed for MEDLINE]
Free Article
8.

Insulin-like growth factor-I inhibits progesterone receptor expression in breast cancer cells via the phosphatidylinositol 3-kinase/Akt/mammalian target of rapamycin pathway: progesterone receptor as a potential indicator of growth factor activity in breast cancer.

Cui X, Zhang P, Deng W, Oesterreich S, Lu Y, Mills GB, Lee AV.

Mol Endocrinol. 2003 Apr;17(4):575-88. Epub 2003 Jan 2. Erratum in: Mol Endocrinol. 2003 Sep;17(9):1892.

PMID:
12554765
[PubMed - indexed for MEDLINE]
9.

A chimeric humanized single-chain antibody against the type I insulin-like growth factor (IGF) receptor renders breast cancer cells refractory to the mitogenic effects of IGF-I.

Sachdev D, Li SL, Hartell JS, Fujita-Yamaguchi Y, Miller JS, Yee D.

Cancer Res. 2003 Feb 1;63(3):627-35.

PMID:
12566306
[PubMed - indexed for MEDLINE]
Free Article
10.

Insulin receptor substrates mediate distinct biological responses to insulin-like growth factor receptor activation in breast cancer cells.

Byron SA, Horwitz KB, Richer JK, Lange CA, Zhang X, Yee D.

Br J Cancer. 2006 Nov 6;95(9):1220-8. Epub 2006 Oct 17.

PMID:
17043687
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

Regulation of breast cancer cell motility by insulin receptor substrate-2 (IRS-2) in metastatic variants of human breast cancer cell lines.

Jackson JG, Zhang X, Yoneda T, Yee D.

Oncogene. 2001 Nov 1;20(50):7318-25.

PMID:
11704861
[PubMed - indexed for MEDLINE]
Free Article
12.

Epidermal growth factor induces insulin receptor substrate-2 in breast cancer cells via c-Jun NH(2)-terminal kinase/activator protein-1 signaling to regulate cell migration.

Cui X, Kim HJ, Kuiatse I, Kim H, Brown PH, Lee AV.

Cancer Res. 2006 May 15;66(10):5304-13.

PMID:
16707456
[PubMed - indexed for MEDLINE]
Free Article
13.
14.

Nitric oxide inhibits the proliferation and invasion of pancreatic cancer cells through degradation of insulin receptor substrate-1 protein.

Sugita H, Kaneki M, Furuhashi S, Hirota M, Takamori H, Baba H.

Mol Cancer Res. 2010 Aug;8(8):1152-63. doi: 10.1158/1541-7786.MCR-09-0472. Epub 2010 Jul 27.

PMID:
20663861
[PubMed - indexed for MEDLINE]
Free Article
15.

Enhancement of insulin-like growth factor signaling in human breast cancer: estrogen regulation of insulin receptor substrate-1 expression in vitro and in vivo.

Lee AV, Jackson JG, Gooch JL, Hilsenbeck SG, Coronado-Heinsohn E, Osborne CK, Yee D.

Mol Endocrinol. 1999 May;13(5):787-96.

PMID:
10319328
[PubMed - indexed for MEDLINE]
16.

Retinoic acid-induced growth arrest of MCF-7 cells involves the selective regulation of the IRS-1/PI 3-kinase/AKT pathway.

del Rincón SV, Rousseau C, Samanta R, Miller WH Jr.

Oncogene. 2003 May 29;22(22):3353-60.

PMID:
12776186
[PubMed - indexed for MEDLINE]
17.

Activation of the insulin-like growth factor 1 signaling pathway by the antiapoptotic agents aurintricarboxylic acid and evans blue.

Beery R, Haimsohn M, Wertheim N, Hemi R, Nir U, Karasik A, Kanety H, Geier A.

Endocrinology. 2001 Jul;142(7):3098-107.

PMID:
11416032
[PubMed - indexed for MEDLINE]
18.

Platelet-derived growth factor negatively regulates the insulin-like growth factor signaling pathway through the coordinated action of phosphatidylinositol 3-kinase and protein kinase C beta I.

Lassarre C, Legay C, Karam M, Ricort JM.

Biochim Biophys Acta. 2013 Jun;1833(6):1367-77. doi: 10.1016/j.bbamcr.2013.02.019. Epub 2013 Feb 24.

PMID:
23481042
[PubMed - indexed for MEDLINE]
Free Article
19.

Mono- or dual-phosphorylation of akt kinase is regulated by distinct receptors that involve the common insulin receptor substrate.

Schnyder B, Lahm H, Pittet M, Schnyder-Candrian S.

J Recept Signal Transduct Res. 2002 Feb-Nov;22(1-4):213-28.

PMID:
12503617
[PubMed - indexed for MEDLINE]
20.

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk